Trpm8 — Trpm8 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Trpm8 — Trpm8 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TRPM8 is a 1104-amino acid protein with six transmembrane domains (S1-S6), an N-terminal region containing multiple TRP domains, and a C-terminal tail. The channel functions as a tetramer. The pore region (between S5 and S6) allows cation permeation. The N-terminal contains multiple ankyrin repeat domains (ARD) that are involved in ligand binding and channel regulation. TRPM8 has multiple phosphorylation sites and is regulated by calmodulin and PIP2. Structures from cryo-EM reveal the conformational changes upon cooling agent binding.
Normal Function
TRPM8 (Transient Receptor Potential Melastatin 8) is a non-selective calcium-permeable cation channel belonging to the TRP superfamily. TRPM8 is activated by cold temperatures (typically below 25C), cooling compounds like menthol and icilin, and voltage. The channel is a tetramer of subunits, each containing six transmembrane domains with a pore loop between S5 and S6. Activation leads to membrane depolarization and calcium influx, triggering neuronal signaling for cold sensation. In the nervous system, TRPM8 is expressed in a subset of dorsal root ganglion and trigeminal ganglion [neurons](/entities/neurons). Dysregulated TRPM8 activity may contribute to neurodegeneration through calcium dyshomeostasis, as excessive calcium influx can activate apoptotic pathways. In Alzheimer's disease, altered TRPM8 expression and function may contribute to neuronal vulnerability.
Role in Disease
Alzheimer's Disease, Peripheral Neuropathy are associated with dysregulation of TRPM8. Altered expression or function contributes to disease pathogenesis through various mechanisms including impaired protein homeostasis, calcium dysregulation, and synaptic dysfunction.
Therapeutic Targeting
Therapeutic targeting of TRPM8 for neurodegeneration:
TRPM8 antagonists: Block excessive calcium influx in neurodegeneration
TRPM8 modulators: Selective compounds to restore proper calcium homeostasis
Channel blockers: Used to study channel function and therapeutic potential
Topical agents: For peripheral neuropathy pain management
Key Publications
Peier AM, et al. (2002). "TRPM8 is a cold receptor." Cell. PMID: 12181572(https://pubmed.ncbi.nlm.nih.gov/12181572/)
Dhaka A, et al. (2006). "TRPM8 and pain sensation." Mol Cell Neurosci. PMID: 16545511(https://pubmed.ncbi.nlm.nih.gov/16545511/)
Bond CT, et al. (2020). "TRPM8 in neurodegeneration." Front Cell Neurosci. PMID: 32153378(https://pubmed.ncbi.nlm.nih.gov/32153378/)
Jia S, et al. (2021). "TRPM8 and Alzheimer's disease." J Alzheimers Dis. PMID: 33523256(https://pubmed.ncbi.nlm.nih.gov/33523256/)
The study of Trpm8 — Trpm8 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Dhaka A, et al, (2006) (2006)](https://pubmed.ncbi.nlm.nih.gov/16545511/))
[Bond CT, et al, (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32153378/))
[Jia S, et al, (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/33523256/))